Impact of dual lipid-lowering strategy with ezetimibe and atorvastatin on coronary plaque regression in patients with percutaneous coronary intervention: the …
K Tsujita, S Sugiyama, H Sumida, H Shimomura… - Journal of the American …, 2015 - jacc.org
Background: Despite standard statin therapy, a majority of patients retain a high “residual
risk” of cardiovascular events. Objectives: The aim of this study was to evaluate the effects of …
risk” of cardiovascular events. Objectives: The aim of this study was to evaluate the effects of …
[引用][C] Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention
K Tsujita, S Sugiyama, H Sumida… - Journal of the American …, 2015 - cir.nii.ac.jp
Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque
Regression in Patients With Percutaneous Coronary Intervention | CiNii Research CiNii 国立 …
Regression in Patients With Percutaneous Coronary Intervention | CiNii Research CiNii 国立 …
Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention: The …
K Tsujita, S Sugiyama, H Sumida, H Shimomura… - 2015 - pubmed.ncbi.nlm.nih.gov
Background Despite standard statin therapy, a majority of patients retain a high" residual
risk" of cardiovascular events. Objectives The aim of this study was to evaluate the effects of …
risk" of cardiovascular events. Objectives The aim of this study was to evaluate the effects of …
[HTML][HTML] Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention …
K Tsujita, S Sugiyama, H Sumida, H Shimomura… - Journal of the American …, 2015 - Elsevier
Background Despite standard statin therapy, a majority of patients retain a high “residual
risk” of cardiovascular events. Objectives The aim of this study was to evaluate the effects of …
risk” of cardiovascular events. Objectives The aim of this study was to evaluate the effects of …
Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention: The …
K Tsujita, S Sugiyama, H Sumida… - Journal of the …, 2015 - europepmc.org
Background Despite standard statin therapy, a majority of patients retain a high" residual
risk" of cardiovascular events. Objectives The aim of this study was to evaluate the effects of …
risk" of cardiovascular events. Objectives The aim of this study was to evaluate the effects of …
Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention
K Tsujita, S Sugiyama, H Sumida, H Shimomura… - Journal of the American …, 2015 - infona.pl
Despite standard statin therapy, a majority of patients retain a high “residual risk” of
cardiovascular events. The aim of this study was to evaluate the effects of ezetimibe plus …
cardiovascular events. The aim of this study was to evaluate the effects of ezetimibe plus …